Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q. Alzheimer’s Disease: Epidemiology and Clinical Progression. Neurol Ther. 2022;11(2):553–69.

Article  PubMed  PubMed Central  Google Scholar 

Alzheimer’s disease facts and figures. Alzheimers Dement. 2023;19(4):1598–695.

Article  Google Scholar 

Perneczky R, Jessen F, Grimmer T, Levin J, Flöel A, Peters O, et al. Anti-amyloid antibody therapies in Alzheimer’s disease. Brain. 2023;146(3):842–9.

Article  PubMed  Google Scholar 

Song C, Shi J, Zhang P, Zhang Y, Xu J, Zhao L, et al. Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond. Transl Neurodegener. 2022;11(1):18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nicoll JAR, Buckland GR, Harrison CH, Page A, Harris S, Love S, et al. Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer’s disease. Brain. 2019;142(7):2113–26.

Article  PubMed  PubMed Central  Google Scholar 

Kim CK, Lee YR, Ong L, Gold M, Kalali A, Sarkar J. Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures. J Alzheimers Dis. 2022;87(1):83–100.

Article  PubMed  PubMed Central  Google Scholar 

Yiannopoulou KG, Anastasiou AI, Zachariou V, Pelidou SH. Reasons for failed trials of disease-modifying treatments for alzheimer disease and their contribution in recent research. Biomedicines. 2019;7(4):97. https://doi.org/10.3390/biomedicines7040097.

van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in Early Alzheimer’s Disease. N Engl J Med. 2022;388(1):9–21.

Article  PubMed  Google Scholar 

Diniz BS. Immunotherapy in alzheimer's disease: from the bench to the bedside. Am J Geriatr Psychiatry. 2024;32(5):584–5.

Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, et al. Vascular dysfunction-The disregarded partner of Alzheimer’s disease. Alzheimers Dement. 2019;15(1):158–67.

Article  PubMed  Google Scholar 

Eisenmenger LB, Peret A, Famakin BM, Spahic A, Roberts GS, Bockholt JH, et al. Vascular contributions to Alzheimer’s disease. Transl Res. 2023;254:41–53.

Article  CAS  PubMed  Google Scholar 

Sur S, Lin Z, Li Y, Yasar S, Rosenberg P, Moghekar A, et al. Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance. Neurology. 2020;95(8):e962–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luckhaus C, Flüß MO, Wittsack HJ, Grass-Kapanke B, Jänner M, Khalili-Amiri R, et al. Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer’s dementia by perfusion-weighted magnetic resonance imaging. Neuroimage. 2008;40(2):495–503.

Article  PubMed  Google Scholar 

Thomas B, Sheelakumari R, Kannath S, Sarma S, Menon RN. Regional Cerebral Blood Flow in the Posterior Cingulate and Precuneus and the Entorhinal Cortical Atrophy Score Differentiate Mild Cognitive Impairment and Dementia Due to Alzheimer Disease. AJNR Am J Neuroradiol. 2019;40(10):1658–64.

CAS  PubMed  PubMed Central  Google Scholar 

Montagne A, Nation DA, Pa J, Sweeney MD, Toga AW, Zlokovic BV. Brain imaging of neurovascular dysfunction in Alzheimer’s disease. Acta Neuropathol. 2016;131(5):687–707.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Swinford CG, Risacher SL, Vosmeier A, Deardorff R, Chumin EJ, Dzemidzic M, et al. Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer’s disease. Neurobiol Aging. 2023;130:103–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Swinford CG, Risacher SL, Wu YC, Apostolova LG, Gao S, Bice PJ, et al. Altered cerebral blood flow in older adults with Alzheimer’s disease: a systematic review. Brain Imaging Behav. 2023;17(2):223–56.

Article  PubMed  Google Scholar 

Iadecola C, Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci. 2007;10(11):1369–76.

Article  CAS  PubMed  Google Scholar 

Kugler EC, Greenwood J, MacDonald RB. The “neuro-glial-vascular” unit: the role of glia in neurovascular unit formation and dysfunction. Frontiers in Cell and Developmental Biology. 2021;9: 732820.

Article  PubMed  PubMed Central  Google Scholar 

Soto-Rojas LO, Pacheco-Herrero M, Martínez-Gómez PA, Campa-Córdoba BB, Apátiga-Pérez R, Villegas-Rojas MM, et al. The neurovascular unit dysfunction in Alzheimer’s disease. Int J Mol Sci. 2021;22(4):2022.

Schaeffer S, Iadecola C. Revisiting the neurovascular unit. Nat Neurosci. 2021;24(9):1198–209.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sweeney MD, Kisler K, Montagne A, Toga AW, Zlokovic BV. The role of brain vasculature in neurodegenerative disorders. Nat Neurosci. 2018;21(10):1318–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iadecola C. The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease. Neuron. 2017;96(1):17–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR Jr, Beckett LA, et al. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer’s disease and mild cognitive impairment. Brain. 2014;137(Pt 5):1550–61.

Article  PubMed  PubMed Central  Google Scholar 

Lourenço CF, Santos RM, Barbosa RM, Cadenas E, Radi R, Laranjinha J. Neurovascular coupling in hippocampus is mediated via diffusion by neuronal-derived nitric oxide. Free Radic Biol Med. 2014;73:421–9.

Article  PubMed  Google Scholar 

Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 2014;508(7494):55–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sweeney MD, Ayyadurai S, Zlokovic BV. Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci. 2016;19(6):771–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sagare AP, Bell RD, Zlokovic BV. Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(10):a011452.

Koizumi K, Wang G, Park L. Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations. Cell Mol Neurobiol. 2016;36(2):155–65.

Article  CAS  PubMed  Google Scholar 

Wang D, Chen F, Han Z, Yin Z, Ge X, Lei P. Relationship Between Amyloid-β Deposition and Blood-Brain Barrier Dysfunction in Alzheimer’s Disease. Front Cell Neurosci. 2021;15: 695479.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Solis E Jr, Hascup KN, Hascup ER. Alzheimer’s Disease: The Link Between Amyloid-β and Neurovascular Dysfunction. J Alzheimers Dis. 2020;76(4):1179–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Z, Wong LW, Su Y, Huang X, Wang N, Chen H, et al. Blood-brain barrier integrity in the pathogenesis of Alzheimer’s disease. Front Neuroendocrinol. 2020;59: 100857.

Article  CAS  PubMed  Google Scholar 

İş Ö, Wang X, Reddy JS, Min Y, Yilmaz E, Bhattarai P, et al. Gliovascular transcriptional perturbations in Alzheimer’s disease reveal molecular mechanisms of blood brain barrier dysfunction. Nat Commun. 2024;15(1):4758.

Article  PubMed  PubMed Central  Google Scholar 

Reddy JS, Allen M, Ho CC, Oatman SR, İş Ö, Quicksall ZS, et al. Genome-wide analysis identifies a novel LINC-PINT splice variant associa